2022-05-31-世界卫生组织-SAGE_Terms_of_reference_4页_145kb

SAGE on Immunization Terms of Reference Summary

1. Overview and Purpose:

• Established in 1999.
• Provides policy and strategic advice on vaccines and immunization to the WHO Director-General.
• Serves as the principal advisory body to WHO on vaccines and immunization, reviewing all public health relevant topics within its scope.

2. Functions (Roles Provided to WHO):

• 1. Policy Advice: Develops normative guidance (e.g., WHO position papers) based on scientific evidence and program implementation considerations.
• 2. Strategic Advice: Reviews WHO/Partner-developed strategies for VPD control/vaccination, evaluates evidence, identifies gaps, and recommends endorsement.
• 3. Monitoring & Evaluation: Provides independent external appraisal of global progress towards vaccination goals and advises on adjustments needed.
• 4. Strategic Foresight & Innovation: Identifies research needs and innovation areas to enhance VPD control effectiveness.

3. Membership (Composition and Criteria):

• Max 20 members serving in their personal capacities.
• Requires diverse technical expertise, geographical representation, and gender balance.
• Appointed by WHO based on an open call for experts.
• Includes a Chair (and Deputies) aiming for gender/geographical representation.
• Appointment Period: Up to 3 years, with possibility of re-election.
• Termination Conditions: Appointed at will if required by WHO; otherwise as per ToR/letter of appointment or by death/resignation.
• Conflicts of Interest (COI) Management:
  • Mandatory declaration of interests form before appointment and upon request.
  • Appointments must pass COI evaluation by WHO; members must respect independence and avoid external instructions.
  • Ongoing duty to report COI changes; may be subject to renewed COI screening before meetings.
• Travel: WHO issue Temporary Adviser Letter for travel which includes mandatory countersignature (linked to COI).
• Compensation: No pay from WHO; Untaxed travel reimbursement applies per in-person meeting.

4. Operation (Meeting and Function):

• Meeting Frequency: Minimum twice/year (WHO determines location, format); can be virtual/open or closed sessions.
• Quorum: Requires 2/3 of members present.
• Sub-Groups: Can establish working sub-groups for specific matters (no formal quorum required).
• Attendance: Missed meetings (esp. two consecutive) may lead to termination.
• Decision Making: Typically by consensus; minority views recorded if consensus not reached.
• Participation Restrictions: Expected to contribute actively (work, calls, meetings). Can't speak officially for SAGE without specific WHO approval; *cannot speak *on behalf of WHO.
• Observers: Can attend (or parts of) open sessions based on invitation – limited functions in information sharing.

5. Secretariat and Documentation Procedures:

• WHO provides SAGE secretariat: meeting logistics, documents (draft position papers).
• All SAGE documentation and work is proprietary/confidential to WHO (until SAGE endorses/withhold recommendations); requires adherence to confidentiality by members/observers.
• WHO controls public release of SAGE reports and recommendations.
• Information and work products created must be exclusively made available by members.